🇺🇸 Skelid in United States

FDA authorised Skelid on 7 March 1997

Marketing authorisations

FDA — authorised 7 March 1997

  • Status: approved

FDA — authorised 7 March 1997

  • Application: NDA020707
  • Marketing authorisation holder: SANOFI AVENTIS US
  • Local brand name: SKELID
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Skelid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Bone approved in United States

Frequently asked questions

Is Skelid approved in United States?

Yes. FDA authorised it on 7 March 1997; FDA authorised it on 7 March 1997.

Who is the marketing authorisation holder for Skelid in United States?

Marketing authorisation holder not available in our data.